<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Rabbit Monoclonal Anti-</title>
  <id>https://www.immbio.hu/</id>
  <link rel="self" href="https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/32/view,rss"/>
  <updated>2014-11-10T11:25:02+01:00</updated>
  <generator>SobiPro</generator>
  <entry>
    <title>AMACR (p504S)</title>
    <author>
      <name>Varga Dávid</name>
    </author>
    <link rel="alternate" href="https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/37-amacr-p504s"/>
    <id>https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/37-amacr-p504s</id>
    <content type="html"/>
    <published>2014-11-10T11:25:02+01:00</published>
    <updated>2014-11-10T11:25:02+01:00</updated>
  </entry>
  <entry>
    <title>bcl-2</title>
    <author>
      <name>Varga Dávid</name>
    </author>
    <link rel="alternate" href="https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/44-bcl-2-1"/>
    <id>https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/44-bcl-2-1</id>
    <content type="html">Bcl-2 is important protein during the process of apoptosis. The antibody may be useful in the classification of follicular lymphomas and various diffuse lymphoproliferative diseases, and for differential identification of diffuse large B-cell lymphoma versus Burkitt lymphoma/leukemia.</content>
    <published>2014-11-10T09:38:58+01:00</published>
    <updated>1970-01-01T01:00:00+01:00</updated>
  </entry>
  <entry>
    <title>c-erbB-2/HER2/neu</title>
    <author>
      <name>Varga Dávid</name>
    </author>
    <link rel="alternate" href="https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/77-c-erbb-2-her2-neu"/>
    <id>https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/77-c-erbb-2-her2-neu</id>
    <content type="html">This antibody recognizes a c-erbB-2 protein, which is a receptor tyrosine kinase of the c­ erbB family. It is closely related in structure to the epidermal growth factor receptor. C-erbB- 2 oncoprotein is detectable in a proportion of breast and other adenocarcinomas, as well as transitional cell carcinomas.&#13;
</content>
    <published>2014-11-10T10:36:49+01:00</published>
    <updated>1970-01-01T01:00:00+01:00</updated>
  </entry>
  <entry>
    <title>CD117 (c-kit)</title>
    <author>
      <name>Varga Dávid</name>
    </author>
    <link rel="alternate" href="https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/71-cd117-c-kit"/>
    <id>https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/71-cd117-c-kit</id>
    <content type="html">This antibody reacts with a 145 kDa molecular weight protein, designated as CD117/c-kit. C-kits are transmembrane receptor tyrosine kinases expressed in many tissues and  cells and are involved  in  the  development  of severa l lineages of stem cells such as germ cells, neuronal crest derived melanocytes and hematopoietic precursor cells. Useful in differentiating gastrointestinal stromal tumors from Kaposi's sarcoma, and tumors of smooth muscle origin.</content>
    <published>2014-11-10T10:15:15+01:00</published>
    <updated>1970-01-01T01:00:00+01:00</updated>
  </entry>
  <entry>
    <title>COX-2</title>
    <author>
      <name>Varga Dávid</name>
    </author>
    <link rel="alternate" href="https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/81-cox-2"/>
    <id>https://www.immbio.hu/hu/palyazatok/cabcos-2/adatbazis/81-cox-2</id>
    <content type="html">COX-2 inhibition by nonsteroidal anti­ inflammatory agents has been shown to decrease angiogenesis and tumor grovvth, and promote apoptosis. COX-2 overexpression has been associated with increased microvascular density, and V EGF protein expression in head and neck squamous cell carcinoma and is an indicator of poor prognosis.</content>
    <published>2014-11-10T10:38:57+01:00</published>
    <updated>1970-01-01T01:00:00+01:00</updated>
  </entry>
</feed>
